Comparison of vortioxetine and sertraline for treatment of major depressive disorder in elderly patients: A double-blind randomized trial.,Journal of Clinical Pharmacy and Therapeutics

当前位置： X-MOL 学术 › J. Clin. Pharm. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Comparison of vortioxetine and sertraline for treatment of major depressive disorder in elderly patients: A double-blind randomized trial.
Journal of Clinical Pharmacy and Therapeutics ( IF 2.1 ) Pub Date : 2020-05-18 , DOI: 10.1111/jcpt.13177
Firouzeh Borhannejad ₁ , Behnam Shariati ₂ , Sina Naderi ₁ , Mohammadreza Shalbafan ₂ , Amirhosein Mortezaei ₁ , Erfan Sahebolzamani ₁ , Atefe Saeb ₂ , Seyyed Hosein Mortazavi ₁ , Leila Kamalzadeh ₂ , Ali Aqamolaei ₁ , Ahmad Ali Noorbala ₃ , Alireza Namazi-Shabestari ₄ , Shahin Akhondzadeh ₁

Affiliation

Major depressive disorder (MDD) is a complex disease and one of the leading contributors to disease burden throughout the world. In the current study, we explored the efficacy and tolerability of vortioxetine versus sertraline on symptoms of depression in elderly patients with MDD.

中文翻译：